Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Carrega

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Leukocyte Biology|February 22, 2023
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cellsGiacomo Sidoti Migliore, Stefania Campana, Chiara Barberi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activationChiara Romagnani, Kerstin Juelke, Michela Falco, et al.
Nature Communications|September 24, 2015
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structuresPaolo Carrega, Fabrizio Loiacono, Emma Di Carlo, et al.
Cancers|January 24, 2019
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with NivolumabJessica Cusato, Carlo Genova, Cristina Tomasello, et al.
Journal of Translational Medicine|May 3, 2013
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α productionStefania Laurent, Paola Queirolo, Silvia Boero, et al.
Cancers|October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer TherapyMelania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
Frontiers in Immunology|March 3, 2020
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung CancerSelene Ottonello, Carlo Genova, Irene Cossu, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2025
BNT162b2 COVID-19 vaccination elicits the expansion of CD16<sup>+</sup>CD8<sup>+</sup> T cells endowed with natural killer cell featuresClaudia De Pasquale, Fabiana Drommi, Alessia Calabrò, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Leukocyte Biology|February 22, 2023
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cellsGiacomo Sidoti Migliore, Stefania Campana, Chiara Barberi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activationChiara Romagnani, Kerstin Juelke, Michela Falco, et al.
Nature Communications|September 24, 2015
NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structuresPaolo Carrega, Fabrizio Loiacono, Emma Di Carlo, et al.
Cancers|January 24, 2019
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with NivolumabJessica Cusato, Carlo Genova, Cristina Tomasello, et al.
Journal of Translational Medicine|May 3, 2013
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α productionStefania Laurent, Paola Queirolo, Silvia Boero, et al.
Cancers|October 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer TherapyMelania Grottoli, Paolo Carrega, Lodovica Zullo, et al.
Frontiers in Immunology|March 3, 2020
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung CancerSelene Ottonello, Carlo Genova, Irene Cossu, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2025
BNT162b2 COVID-19 vaccination elicits the expansion of CD16<sup>+</sup>CD8<sup>+</sup> T cells endowed with natural killer cell featuresClaudia De Pasquale, Fabiana Drommi, Alessia Calabrò, et al.
Pageof 4